Clinical trial
Efficacy and Safety of THR-4109 in Obese Subjects
NCT00485017 · Theracos, Industry · Completed
Key facts
| NCT number | NCT00485017 |
|---|---|
| Title | Efficacy and Safety of THR-4109 in Obese Subjects |
| Official title | A Phase II Randomized, Double-Blind, Double-Dummy, Parallel Group, Placebo Controlled Study of THR-4109 in Obese Subjects |
| Lead sponsor | Theracos, Industry |
| Collaborators | TFS Trial Form Support Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | THR-4109, Placebo |
| Enrollment | 220 |
| Start date | Aug 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 12, 2007 |
| Last update posted | Sep 30, 2019 |
| Countries | Russia, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: